Equities research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for shares of Aligos Therapeutics in a report issued on Tuesday, March 11th. HC Wainwright analyst E.

Houlihan Lokey (NYSE:HLI – Get Free Report) was upgraded by equities researchers at Morgan Stanley from an “underweight” rating to an “overweight” rating in a note issued to investors on Thursday, ...